Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio-Nature Laboratories was a U.S.-based private consumer health and beauty company that operated primarily through the Lily Bioceuticals brand. The business marketed skincare, anti-aging, and wellness/nutraceutical products, including NAD+/nicotinamide riboside-themed products and cosmetic "second skin" offerings. Available public evidence ties the company to New Jersey addresses in Piscataway and Edison and to the LilyHerbs/Lily Bioceuticals e-commerce presence. However, the company appears to be inactive as an operating business, with a Chapter 7 bankruptcy filing in November 2023 and later public signs such as undeliverable business mail reported by BBB. It does not appear to be a drug-development biotech company with a clinical pipeline; rather, it was a commercial direct-to-consumer cosmeceutical and supplement marketer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio-Nature Laboratories.